Michael S. Balzer
LightNews LightNews
banner
balzer-lab.org
Michael S. Balzer
@balzer-lab.org
1.3K followers 2.3K following 160 posts
MD FASN | Nephrologist = kidney doc | #PeritonealDialysis aficionado | #ClinicianScientist @ChariteBerlin | Editorial Board member @JASN | #SingleCell | Determined to understand adaptation to kidney disease | #ERCStG | 🌐 https://balzer-lab.org
Posts Replies Media Videos
balzer-lab.org
Classic Fred Luft #Nephrology 101 editorial on a study testing the effect of potassium supplement on natriuresis: Eliminating sodium with potassium 🔗 academic.oup.com/ndt/article/... #NephSky #MedSky 🧪
February 3, 2026 at 8:25 PM
balzer-lab.org
Excited to share our recent JASN paper on enalapril effects in #DKD using #single-cell approaches.🧪
Thanks to the whole team @nephrointberlin.bsky.social @PennKidney, and @Bayer.

Special 🙏 to my mentor @ksusztak.bsky.social. Her insightful X thread is copied below.

🔗 t.ly/oNjkJ #NephSky #MedSky
January 8, 2026 at 12:44 PM
balzer-lab.org
Check out a recent interesting case of C-H-BG syndrome from @nephrointberlin.bsky.social. A great example of how rare symptoms in a common disease can present with complex phenotypes.
#NephSky #MedSky 🧪
🔗 www.sciencedirect.com/science/arti...
January 3, 2026 at 12:44 PM
balzer-lab.org
Merry Xmas! 🎄
Be kind to your kidneys this holiday season.
#NephSky #MedSky 🫘🧪
A christmas tree ornament reading "He's making a lith and checking it twice", picturing a kidney with Santa's hat.
December 23, 2025 at 11:16 AM
Reposted by Michael S. Balzer
hswapnil.medsky.social
We really don’t think BigPAK makes sense

From our journal club at @uottawa.ca into a #NephJC shorts

www.nephjc.com/news/2025/12...
BigPAK or a bundle of balderdash? — NephJC
We break down the latest salvo from Zarbock et al on a supposedly wonderful ‘bundle’
www.nephjc.com
December 17, 2025 at 11:13 PM
Reposted by Michael S. Balzer
jmteakell.bsky.social
Keep Calm & Carry On
Inhibiting RAS 👑

#Kidneywk #Nephjc

👉 www.nephjc.com/news/stopacei
👉 www.nephjc.com/news/aceing-...
November 8, 2025 at 7:29 PM
balzer-lab.org
👏Huge congratulations to my fantastic mentor @ksusztak.bsky.social for receiving the 2025 ASN Homer Smith award.
nephtimes.bsky.social Nephrology Times @nephtimes.bsky.social · Nov 7
Katalin Susztak accepting the Homer W. Smith Award. #KidneyWk
November 7, 2025 at 2:37 PM
balzer-lab.org
👏Fantastic to see @cetinsz.bsky.social from our team presenting insights into #single-cell transcriptomic patterns distinguishing recovery from non-recovery after #AKI. Exciting 🧪 at #KidneyWk Houston, TX! #MedSky #NephSky
November 6, 2025 at 11:24 PM
balzer-lab.org
❓Do we finally have a nodular sclerosis mouse model for DKD? 🔥Tour-de-force #kidneywk talk by @linkermannlab.bsky.social suggests so. 🧪 #NephSky #MedSky
November 6, 2025 at 9:37 PM
Reposted by Michael S. Balzer
jsantoyo.bsky.social
Cell Decoder: decoding cell identity with multi-scale explainable deep learning. #SingleCellOmics #CellCharacterization #GenomeBiology 🧪🧬 🖥️
genomebiology.biomedcentral.com/articles/10....
October 27, 2025 at 9:31 AM
Reposted by Michael S. Balzer
physaliacourses.bsky.social
🚀 Curious about #SpatialOmics? Want to master spatial omics data analysis using #Rstats and @bioconductor.bsky.social ?

🔥 Registrations are now OPEN for the 3rd edition of our hands-on course with @stemang.bsky.social !

📅 Save the dates: 18–20 May 2026
www.physalia-courses.org/courses-work...
spatial Omics in R/Bioconductor
18-20 May 2026 To foster international participation, this course will be held online
www.physalia-courses.org
October 7, 2025 at 3:05 PM
balzer-lab.org
🚀Excited to announce that I’ve been awarded an @erc.europa.eu StG to advance research how kidneys heal themselves — a paradigm shift for understanding & treating #kidneydisease 🫘🩺🧬🧪
👉ERC press release: t.ly/CBxwB
👉Charité press release: t.ly/SR_Wn
#ERCStG #HorizonEU #KidneyResearch #NephSky #MedSky
The ERC awards €761m to the next generation of scientists in Europe
The European Research Council (ERC) has selected 478 early-career researchers across Europe to receive this year’s Starting Grants. With a total funding of €761 million, these grants support excellent...
t.ly
September 4, 2025 at 11:21 AM
Reposted by Michael S. Balzer
kpmproject.bsky.social
📑 Need something to read this weekend? If so, you're in luck!

"Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules" fueled by #KPMP investigators is hot off the press today @science.org

www.science.org/doi/10.1126/...
Integration of spatial protein imaging and transcriptomics in the human kidney tracks the regenerative potential of proximal tubules
The interplay in expression of the stem cell markers THY1 and PROM1 in kidney proximal tubules marks the timeline of disease.
www.science.org
August 15, 2025 at 8:15 PM
balzer-lab.org
🔥 Huge congrats to @ksusztak.bsky.social & team on a landmark @natgenet.nature.com paper!
🚶‍♂️🐁🐀Cross-species 🫘kidney pathway dysregulation via #singlecell functional profiling of individual samples — opening new therapeutic avenues.
🔗 www.nature.com/articles/s41...
🧪 #NephSky #MedSky
August 8, 2025 at 8:08 AM
balzer-lab.org
🔥Paper alert @nature.com. Fantastic 🧪resource for the renal 🫘 community! #NephSky #MedSky

Congrats @puellesv.bsky.social lab and team!
pjsaez.bsky.social Pablo J. Sáez @pjsaez.bsky.social · Jul 18
#HotFromThePress !!

What if instead of analyzing 4-6 pathology markers you could check >100 in the *same* sample?

@maltekuehl.com & co @puellesv.bsky.social lab introduce #PathoPlex, method that could even predict disease

Full www.nature.com/articles/s41...
@focalplane.bsky.social @nature.com 🧪🔬
July 20, 2025 at 12:06 PM
Reposted by Michael S. Balzer
natrevneph.nature.com
Pregnancy-associated acute kidney injury — consensus report of the 32nd Acute Disease Quality Initiative workgroup
Nature Reviews Nephrology, Published online: 18 July 2025; doi:10.1038/s41581-025-00979-6Pregnancy-associated acute kidney injury is a risk factor for maternal and fetal morbidity and mortality and a driver of health inequity worldwide. This Consensus Statement from the Acute Disease Quality Initiative provides recommendations on the causes, diagnosis, management and follow-up of pregnancy-associated acute kidney injury.
www.nature.com
July 18, 2025 at 12:30 PM
Reposted by Michael S. Balzer
kidneyint.bsky.social
Randomized, Double-Blind, Placebo-Controlled Phase 2a Study Assessing the Efficacy and Safety of Felzartamab for IgA Nephropathy

doi.org/10.1016/j.kint.2025.05.028

#OpenAccess #IgAN #felzartamab #IgANephropathy
July 7, 2025 at 3:16 PM
Reposted by Michael S. Balzer
jtkidney.bsky.social
Simon Davies kicking off day 2 of the 1st International Meeting on
Cellular and Molecular Peritonial Dialysis Research in Kiel.
July 5, 2025 at 7:13 AM
balzer-lab.org
👏Congrats to the KidneyCure 2025 Grant Recipients! 🫘🧪
@asnpublications.bsky.social #NephSky #MedSky
KidneyCure 2025 Grant Recipients
July 1, 2025 at 2:52 PM
Reposted by Michael S. Balzer
nejm.org
In the latest video in our partnership with @glaucomflecken.bsky.social, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free: nej.md/DrG19
June 21, 2025 at 10:53 AM
Reposted by Michael S. Balzer
ispd.org
The Fellowship Program is one of the ISPD’s key instruments to strengthen global PD expertise through hands-on learning and knowledge exchange.

Learn more about the results of our first call for applications in 2025 and the new application modality for teams Doctor-Nurse.

buff.ly/7XjuPCM
ISPD Fellowship results - 1st call 2025 - International Society for Peritoneal Dialysis
The Fellowship Program is one of the ISPD’s key programs to strengthen global PD expertise through hands-on learning and knowledge exchange. For the first round of 2025, we received 17…
buff.ly
June 22, 2025 at 7:13 AM
Reposted by Michael S. Balzer
nejm.org
In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results: nej.md/4jEVbbk

#ERA25 #MedSky #Nephrology
A graph of the least-squares mean ratio of the change from baseline in the urinary albumin-to-creatinine ratio in the full analysis population.
June 5, 2025 at 9:45 AM
balzer-lab.org
🎉🎈Congrats to all ASN 2025 🏆Lifetime & Midcareer awardees!

Well-deserved, @ksusztak.bsky.social @rkramann.bsky.social @genetickidneydoc.bsky.social, you are on 🔥!!!
#NephSky, #MedSky, #ERA25
ASN Lifetime & Midcareer Awardees 2025
June 4, 2025 at 4:47 PM
Reposted by Michael S. Balzer
asnpublications.bsky.social
In the May 2025 #ASNKidneyNews Policy Update, explore recent new and existing policy actions from ASN Advocacy that benefit physicians, patients, and researchers. bit.ly/KN1705-16
May 31, 2025 at 5:29 PM
Reposted by Michael S. Balzer
hswapnil.medsky.social
The effect of disappearing data from US public health

#OpenAccess viewpoint in @thelancet.com

www.thelancet.com/journals/lan...

#MedSky #EpiSky
Figure Full season (32-week-ahead) forecasts of influenza hospitalisations in the USA
May 27, 2025 at 2:24 PM